Loss of TET2 caused an impressive decrease in the 5hmC levels, especially at ER cis-regulatory elements, which emphasized again the essential role of TET2 in mediating the transcription of ER target genes particularly in breast cancer cells [50]. The gene discussed is TET2; the disease is breast carcinoma.